Skip to content
Lower risk Drug recall · FDA · Published June 28, 2018

Lupin Somerset Nitrofurantoin Oral Suspension Recall: Subpotent Drug Risk

Lupin Somerset recalls 230mL Nitrofurantoin Oral Suspension due to subpotent drug and failed content uniformity. This may not provide effective treatment for urinary tract infections. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #D-0927-2018DrugLupin Somerset ›
Take action

Contact the company

Recalling firmLUPIN SOMERSET400 Campus Dr · Somerset, NJ 08873-1145
✎ GovInfoNow plain-language explainer

Lupin Somerset is recalling 230mL bottles of Nitrofurantoin Oral Suspension (25mg/5mL) because the medication may not be strong enough to treat urinary tract infections. This could lead to ineffective treatment if used without proper dosage. Read more at govinfonow.com/recall/40392-lupin-somerset-nitrofurantoin-oral-suspension-recall-subpotent-drug-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/40392-lupin-somerset-nitrofurantoin-oral-suspension-recall-subpotent-drug-risk · Updated October 6, 2026 · FDA enforcement record: FDA #D-0927-2018

Cite this page

“Lupin Somerset Nitrofurantoin Oral Suspension Recall: Subpotent Drug Risk.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/40392-lupin-somerset-nitrofurantoin-oral-suspension-recall-subpotent-drug-risk. Based on FDA recall #D-0927-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0927-2018%22&limit=1).

The FDA announced on June 28, 2018, that Lupin Somerset is recalling Nitrofurantoin Oral Suspension USP due to subpotent drug and failed content uniformity hazards. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Lupin Somerset
  • Product: Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle
  • UPC: 00343386450114 (also listed as 343386-450-11)
  • Lot codes: S700065 (Exp. 02/2019), 700619 (Exp. 08/2019)
  • Units affected: 3,456 cartons

The hazard

The recall cites subpotent drug and failed content uniformity as the primary hazards. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show Lupin Somerset has 8 other recalls on record since May 24, 2018. Other recent recalls of similar products include Lupin Somerset Morphine Sulfate Tablets Recall (April 10, 2019), Lupin Recalls Gavilyte-N Packets Due to Labeling Error (March 19, 2019), and Lupin Recalls Fluocinolone Acetonide Topical Solution Due to Impurities (Jan. 15, 2019). Additional recent recalls include Somerset Therapeutics Cisatracurium Besylate Injection Recall (Nov. 26, 2025), Lupin prednisolone acetate ophthalmic suspension recall (June 4, 2026), and Lupin Ganirelix Acetate Injection Recall (Nov. 13, 2025).

How to tell if you have this one

Check for the 230mL bottle labeled Nitrofurantoin Oral Suspension USP, 25mg/5mL, Rx Only. The product was manufactured by Novel Laboratories, Inc. and distributed by Lupin Pharmaceuticals, Inc.

  • Brand
    Lupin Somerset
  • Product
    Nitrofurantoin Oral Suspension USP, 25mg/5mL, 230 mL Bottle, Rx Only, Manufactured by: Novel Laboratories, Inc
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Manufacturer

    Reach out to Lupin Pharmaceuticals, Inc. for specific instructions on handling the recalled product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the US” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4.7 years after the firm started it.

1. Firm started the recall: Jun 28, 201812. FDA classified it Class II: Jul 18, 201823. Published in FDA’s Enforcement Report: Jul 18, 201834. FDA terminated the recall: Mar 6, 2023420182023
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0927-2018 (June 28, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0927-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA